Astex achieves second milestone in Alzheimer’s drug discovery collaboration with AstraZeneca

Astex achieves second milestone in Alzheimer’s drug discovery collaboration with AstraZeneca

SuperGen’s New Drug Application for Orathecin™ (rubitecan) Capsules Accepted by FDA for Filing

SuperGen’s New Drug Application for Orathecin™ (rubitecan) Capsules Accepted by FDA for Filing

Astex, The Wellcome Trust, The Institute of Cancer Research and Cancer Research Technology announce major cancer drug discovery collaboration

Astex, The Wellcome Trust, The Institute of Cancer Research and Cancer Research Technology announce major cancer drug discovery collaboration

SuperGen Releases Interim Data Clarification From Dacogen™ Phase III Clinical Study in Myelodysplastic Syndrome Following Analyst/Investigator Conference Call

SuperGen Releases Interim Data Clarification From Dacogen™ Phase III Clinical Study in Myelodysplastic Syndrome Following Analyst/Investigator Conference Call

Published Study Results Show Low-Dose Outpatient Dosing Schedule of Dacogen™ Useful in Patients With Hematological Malignancies

Published Study Results Show Low-Dose Outpatient Dosing Schedule of Dacogen™ Useful in Patients With Hematological Malignancies